Home › Merck Signs Sale Agreement with Santen for Mercks Ophthalmology Products in Japan and Key Markets in Europe and Asia Pacific
 

Keywords :   


Merck Signs Sale Agreement with Santen for Mercks Ophthalmology Products in Japan and Key Markets in Europe and Asia Pacific

2014-05-13 08:15:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that it signed an agreement for Santen Pharmaceutical Co., Ltd. Language: English Contact: MerckMedia:Caroline Lappetito, 267-218-1584orMamoru Ohara, 81-3-6272-1001orInvestor:Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: products key sale japan

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.10Hurricane Milton Probabilistic Storm Surge Graphics
07.10Customers of failed crypto firm FTX set for refunds
07.10Hurricane Milton Graphics
07.10Hurricane Milton Storm Surge Watch/Warning Map
07.10Hurricane Milton Forecast Advisory Number 11
07.10Hurricane Leslie Graphics
07.10Hurricane Leslie Wind Speed Probabilities Number 22
07.10Hurricane Leslie Public Advisory Number 22
More »